Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2026-02-23 @ 12:22 PM
Study NCT ID:
NCT02179151
Status:
TERMINATED
Last Update Posted:
2017-01-26
First Post:
2014-06-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Sponsor:
Zafgen, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09
Start Date Type:
None
Primary Completion Date:
2015-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-10
Completion Date Type:
ACTUAL
First Submit Date:
2014-06-25
First Submit QC Date:
None
Study First Post Date:
2014-07-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2017-01-26
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-01-24
Last Update Post Date:
2017-01-26
Last Update Post Date Type:
ESTIMATED